These authors contributed equally to this work.
Introduction
X-linked adrenoleukodystrophy is a rare inherited metabolic disease caused by loss-of-function mutations in the ABCD1 gene, which is located in the X chromosome and encodes for the peroxisomal ABCD1 transporter of very long-chain fatty acids (VLCFAs). Adrenomyeloneuropathy is the most common adult-onset X-linked adrenoleukodystrophy phenotype, and is considered the most frequent metabolic hereditary spastic paraplegia. Key neurological adrenomyeloneuropathy features are slowly progressive spastic paraparesis, and sensory and autonomic dysfunctions, which are related to a dying-back axonal degeneration of the long tracts of the spinal cord, mostly the cortico-spinal and dorsal column tracts (Semmler et al., 2008) .
Different potential disease-modifying therapies, including antioxidant treatments and pharmacological upregulation of other peroxisomal ABC transporters (Semmler et al., 2008) , are under use or under preclinical or clinical investigations for adrenomyeloneuropathy therapy, but to date there is no definite proof of, or it will be hard to definitely prove, their efficacy in clinical studies. This is partially due to the rarity of the disease, the slow disease progression, and the low sensitivity of the clinical scores in detecting disease evolution when clinical studies are carried out in a relatively short time course (1 or 2 years), with a small number of patients, or both. Therefore, it is fundamental to identify biomarkers that allow a reliable quantification of disease progression in small-scale studies, and possibly within a short time frame.
Quantitative MRI has been largely used for identifying, characterizing and quantifying structural changes of the brain in many neurological diseases, including hereditary neurodegenerative diseases and hereditary spastic paraplegias (Mascalchi et al., 2004; Rosas et al., 2006; Agosta et al., 2015) . Moreover, quantitative MRI-derived measures of the brain might reveal longitudinal changes that make them attractive as surrogate outcome measures (Harrison et al., 2011; Poudel et al., 2015) , despite their external validity is still a matter of concern (Rothwell, 2005) . In contrast, there are few studies investigating quantitative MRI of the spinal cord for clinical purposes, because of acquisition issues, scanner variability, and lack of reference values Wheeler-Kingshott et al., 2014) . Recent methodological advances suggest that quantitative MRI can be successfully used to assess structural changes of the spinal cord (Toosy et al., 2014) , making this strategy attractive for assessing hereditary degenerative slowly progressive diseases such as adrenomyeloneuropathy, which are characterized by the prominent involvement of spinal cord.
In this work, we applied quantitative MRI techniques for identifying, characterizing and quantifying structural changes of the upper spinal cord and brain in a cohort of subjects with different severity of adrenomyeloneuropathy, in comparison with healthy controls. In particular, we evaluated the degree of upper spinal cord atrophy, and we used diffusion tensor imaging (DTI) to assess the cervical spinal cord, and brain microstructural changes; subsequently, we assessed the correspondence of quantitative MRI-derived measures with the expected histopathology of the disease, and their correlation with the clinical status of our patients.
Materials and methods

Study design, setting and participants
We used a cross-sectional design to compare 13 Italian adult (518 years of age) patients with adrenomyeloneuropathy to 12 age-and sex-matched healthy volunteer control subjects. The patients were enrolled consecutively from June 2013 to December 2014 at the Adult Leukodystrophy Outpatient Clinic of the Fondazione IRCCS Istituto Neurologico 'C. Besta', Milano, Italy. All the patients had a biochemical and genetic diagnosis of X-linked adrenoleukodystrophy, and a clinical and brain MRI diagnosis of adrenomyeloneuropathy, due to the predominant presence of motor, sensory and/or autonomic neurological dysfunctions without any lobar white matter changes on conventional brain MRI (Kö hler, 1999) . They all underwent neurological examination including the Kurtzke's functional system and Expanded Disability Status Scale (EDSS) (Kurtzke, 1983) , clinical score for adult patients with X-linked adrenoleukodystrophy (ALD score) (Kö hler, 1999) , and Ambulation Index (Hauser et al., 1983 ) within 1 week before or after the quantitative MRI assessment. The mean patients' age was 37.8 AE 6.8 years, with a mean disease duration of 10.5 AE 4.3 years. The volunteer controls were male healthy individuals without any clinical and radiological evidence of neurological diseases. The mean age of controls subjects was 34.6 AE 4.5 years. The study was performed as per ethics committee-approved guidelines, and all the participants signed informed consent form.
Image acquisitions
All subjects were scanned on a 3 T scanner (3T Achieva, Philips Healthcare) equipped with 80 mT/m gradients using a phased-array head 8 channel-coil and a 16-channel phasedarray head and neck coil for cervical spine imaging.
The following sequences were acquired: (i) sagittal cervical and thoracic spinal cord T 2 -weighted turbo spin-echo (TSE), sagittal cervical 3D T 1 -weighted fast field-echo (3D-T1 FFE) images and axial DTI acquisitions with diffusion gradients applied along six axes, using a b-value of 0 and 600 s/mm 2 ; and (ii) brain axial T 2 -weighted TSE, axial 3D fluid-attenuated inversion-recovery (3D-FLAIR), axial 3D-T1 FFE images and axial single-shot echo-planar sequence for DTI, with diffusion gradients applied along 32 axes, using a b-value of 0 and 1000 s/mm Two experienced neuroradiologists (L.S.P., with 16 years of experience and A.C., with 9 years of experience) blindly revised all the brain and spinal cord images to detect any abnormality.
Image analyses
MRI analysis was performed by two experienced observers, one neuroradiologist (A.C., with 9 years of experience) and one magnetic resonance physicist (N.P., with 10 years of experience in neuroimaging), who were blinded to the clinical information.
Spinal cord atrophy assessment
One observer (A.C.), masked to the clinical information, assessed the total cord areas at all the intervertebral cervical disc levels and the upper thoracic levels down to T2-3, after reslicing to a 1 mm isotropic voxel the 3D-T 1 fast field-echo images othogonally to the spinal cord using the software JIM6 (Xinapse Systems, www.xinapse.com) (Horsfield et al., 2010) . For each level the average total cord area on a 5 mm slab was semi-automatically measured by using the same parameters described in Papinutto et al. (2015) . A second reader (N.P.) performed the same measurements on three selected cervical and thoracic levels (C2-3, C5-6 and T2-3) to assess inter-operator reliability. An additional analysis was also performed at the C2-3 level, by measuring the main 2D diameters of the cord (Sherman et al., 1990) : major antero-posterior, major transverse, middle anterior transverse, middle posterior transverse, middle left antero-posterior, middle right anteroposterior.
Diffusion tensor imaging processing
After correcting for distortions due to eddy currents and head motion, maps of fractional anisotropy, mean diffusivity, axial diffusivity and radial diffusivity were derived from brain and spine diffusion acquisitions by fitting the diffusion tensor model within each voxel using the FMRIB Diffusion Toolbox (FDT tool, FMRIB Software Library [FSL] version 5.0.4; http://www.fmrib.ox.ac.uk).
Spinal cord diffusion tensor imaging analysis
Mean fractional anisotropy, and mean axial and radial diffusivity on grey and white matter regions of interest were assessed at the C2-3, C3-4 and C4-5 levels.
Briefly, the T 2 -weighted images, cord and grey matter probabilistic masks of the three disc levels were extracted by the MNI-poly-AMU template (Fonov et al., 2014) . The corresponding slices were extracted by the computed fractional anisotropy images and coregistered to the T 2 -weighted images using a 2D transformation with the Advanced Normalization Tools (ANTS, Release 1.9). These transformations were then applied to mean, axial and radial diffusivity maps.
The grey matter regions of interest were extracted by the atlas and thresholded to a value of 0.4, which gave grey matter area to total cord area ratios in accordance with Papinutto et al. (2015) . White matter regions of interest were obtained as difference between the total cord area region of interest and the grey matter region of interest.
As any a priori information about the presence and the degree of grey matter atrophy in the spinal cord of adrenomyeloneuropathy patient is unknown, we eroded the white and grey matter regions of interest by layer of about two voxels, to avoid partial volume contributions in the estimate of DTI measures in the two compartments.
Automated parcellation of brain T 1 images
FreeSurfer Image Analysis Suite version 5 (http://surfer.nmr. mgh.harvard.edu/) was used for cortical reconstruction, volumetric segmentation and cortical parcellation (Fischl et al., 2004) , as well as determining cortical thickness in each volume of interest and volumetric assessment of deep grey matter nuclei volumes. The Desikan-Killiany Atlas in Freesurfer was used to obtain 34 grey matter volumes of interest per hemisphere in the native coordinate system of each subject Fischl et al., 1999; Desikan et al., 2006) . Segmentation results were assessed by an experienced neuroradiologist (A.C.) to ensure accuracy. Volumes were normalized for total intracranial volume (Desikan et al., 2006) .
Brain grey matter diffusion evaluation
Brain DTI maps were registered to the T 1 -weighted images with both an affine alignment using FLIRT (FMRIB's Linear Image Registration Tool) and a non-linear registration using FNIRT. The same transformations were then applied to the 34 cortical volumes of interest in each hemisphere and the deep grey matter nuclei volumes. Mean fractional anisotropy and mean diffusivity values were finally calculated in these volumes of interest for each subject.
Tract-based spatial statistics analysis
Voxel-wise tract-based spatial statistics (TBSS) analysis was performed using the default FSL pipeline (Smith et al., 2006) . Each fractional anisotropy image was first aligned to every other one, to identify the 'most representative' subject of the group. The identified target image was affine-aligned into the Montreal Neurological Institute (MNI) standard space, and every subject's fractional anisotropy image transformed into the standard space by combining the non-linear transformation to the target fractional anisotropy image with the affine transformation from that target to the MNI space. An average fractional anisotropy image was created and 'skeletonized' in a mean fractional anisotropy skeleton using a fractional anisotropy threshold of 0.2 to include only white matter voxels. Finally, for each subject's fractional anisotropy image, the maximum fractional anisotropy value perpendicular to each voxel of the skeleton was projected onto this skeleton to perform the voxel-wise statistical analysis. The mean, axial and radial diffusivity images were transformed to the MNI space and to the skeleton by using the same transformations. Comparisons of fractional anisotropy, and mean, axial and radial diffusivity between patients and controls were done by using a two-sample independent t-test. The resulting statistical maps were corrected for multiple comparisons [family-wise error (FWE) correction using the TFCE (Threshold-Free Cluster Enhancement) option in randomize] and thresholded at a significance level P = 0.001.
Tractography-based analysis
To understand the relative contribution of axial and radial diffusivity to either mean diffusivity or fractional anisotropy changes, we performed a tractography-based analysis on corticospinal tracts in the brain of patients with adrenomyeloneuropathy and control subjects. We obtained 3D reconstructions of the corticospinal tracts using the fibre association by continuous tractography (FACT) method by using Trackvis (http://www.trackvis.org). Tracts were reconstructed using fractional anisotropy and the principal eigenvector of the diffusion tensor. Whole-brain seeding was used with predefined thresholds of fractional anisotropy and principal eigenvector turning angle (0.2 and 40 , respectively). To limit the reconstructed corticospinal tracts to their known anatomical course we used a multiple regions of interest approach: one neuroradiologist (A.C., with 9 years of experience in fibre tracking) drew axial regions of interest around the ipsilateral anterior pons and the ipsilateral cerebral subcortical white matter at the level of the precentral gyrus. We selected the fibres that passed through all of these regions of interest, running through the entire intracranial corticospinal tract from the cortex to the medulla. Rare spurious fibres passing through the contralateral anterior and bilateral posterior pons, and other fibres that clearly fell outside the major portion of the corticospinal tract, were then manually excluded. Mean fractional anisotropy, and mean, axial and radial diffusivity were derived both on the entire tracts and on subsegments (medulla, pons, midbrain, internal capsule, corona radiata, subcortical white matter) (Reich et al., 2007) .
Statistical analysis
After testing for normality using the Shapiro-Wilk's test, pairwise comparisons of total cord areas measures at each cervical and upper thoracic level were assessed using the independent samples t-test.
Intraclass correlation coefficients were calculated to assess the inter-observer reliability of the semi-automated total cord area measurements on the three selected cervical and thoracic levels.
The relationships between the total cord areas measures and the clinical measures (EDSS, Ambulation Index and ALD score) were assessed using Pearson correlation coefficients.
Pairwise comparisons of DTI measures at the three cervical levels were assessed using the independent samples t-test. Pearson's correlation was used to assess the correlation between the DTI values and clinical scores at each level.
The Mann-Whitney U-test, with Bonferroni adjustment to correct for multiple comparisons, was used to assess the differences between the patients and controls for cortical thickness, cortical volumes (volumes corrected for total intracranial volume) and mean fractional anisotropy and mean diffusivity in the cortical and deep grey matter nuclei volumes in each hemisphere.
Pairwise comparisons of DTI measures along the entire corticospinal tracts in the brain as well as on their subsegments (medulla, pons, midbrain, internal capsule, corona radiata, subcortical white matter) were calculated using the independent samples t-test. The Pearson correlation coefficients were used to assess the correlation between the diffusion parameters and the clinical data of the patients, as well as the disease duration.
For all the tests, a statistical level of = 0.05 was chosen. The partial least squares regression method was finally used to explain the relative contribution of each quantitative spinal cord and brain metric (total cord areas, spinal cord and brain DTI measures) in separating patients from controls.
Analysis and statistical figures were calculated with SPSS 20.0 for MacOSX (SPSS Inc., IBM, Chicago), MedCalc software, version 14 (MedCalc Software, Ostend, Belgium) and JMP statistical software version 10.0.0 (SAS Institute Inc. Cary, NC, USA).
Results
There was no significant age difference between patients with adrenomyeloneuropathy and healthy control subjects (adrenomyeloneuropathy patients versus healthy controls: 37.8 AE 6.8 versus 34.6 AE 4.5 years; P = 0.18). The mean patient disease duration was 10.5 AE 4.3 years. Regarding the clinical scores, the median EDSS was 6 (range 2-8); the median ALD score was 6 (range 2-16); the median Ambulation Index was 4 (range 0-8).
Pearson coefficients after testing for normality demonstrated a strong, positive correlation between different clinical scores: EDSS and ALD score (r = 0.855, P 5 0.0001), EDSS and Ambulation Index (r = 0.938, P 5 0.0001), ALD score and Ambulation Index (r = 0.906, P 5 0.0001).
Spine atrophy measures
Spine quantitative MRI data of 13 male patients with adrenomyeloneuropathy and 12 age-and gender-matched control subjects were acquired.
Total cord area was significantly smaller in patients compared to controls at all the explored cervical and thoracic levels (Table 1, Fig. 1 and Supplementary Fig. 1) ; the relative reduction was more pronounced at the thoracic levels. Indeed, total cord area was reduced by: 27.1% at C2-3, 28.3% at C3-C4, 28.6% at C4-5, 26.3% at C5-6, 29.4% at C6-7, 35.9% at C7-T1, 39.8% at T1-2 and 40.2% at T2-3. Using the partial least squares analysis, the cord areas alone predict 86% of the variability between patients and controls.
Inter-rater reliability for the total cord area assessments showed intraclass correlation coefficients of 0.996 at C2-3 (P 5 0.001), 0.993 at C5-6 (P 5 0.001) and 0.995 at T2-3 (P 5 0.001), with a mean intraclass correlation coefficient of 0.995, demonstrating an excellent inter-observer reproducibility of these measurements.
At C2-3 level, the relative reduction of the antero-posterior diameters was greater than the reduction of the transverse diameters of the cord (Supplementary Table 1 and Supplementary Fig. 1 ), as well as the percentage reduction of the posterior transverse diameters with respect to the anterior (À14.1% versus À10.1%).
Total cord area at all the explored cervical and thoracic levels did not correlate with disease duration (P 4 0.05), considering or not age as covariate. Total cord area measurements did not correlate with clinical scores (P 4 0.05, adjusted for multiple comparisons).
Spine diffusion tensor imaging measures
DTI analysis revealed a significant reduction of white matter fractional anisotropy at all the explored levels (P 4 0.0003) with a concomitant reduction of axial diffusivity (P 4 0.009) and increase of radial diffusivity (P 4 0.009) (Table 2, Fig. 2 and Supplementary Fig. 2 ). The relative reduction of fractional anisotropy was 15% at C2-3, 18.7% at C3-4 and 14.3% at C4-5; of axial Figure 1 Mean ( AE standard deviation) cervical and thoracic total cord areas in healthy controls (blue) and patients (red). In patients, a significant reduction of the total cord area was observed at all examined levels.
ÃÃÃ P 5 0.0001. diffusivity was 8.9% at C2-3, 12% at C3-4 and 8.2% at C4-5. The percentage increase of radial diffusivity was 30.4% at C2-3, 42.5% at C3-4 and 30.7% at C4-5. Using the partial least squares analysis, the DTI values in the white matter alone predict 85% of the variability between patients and controls. A trend to a reduction of fractional anisotropy in the grey matter of the spinal cord was also observed at the lower cervical level explored (C3-4 and C4-5) (Table 3) . DTI measurements did not correlate with clinical scores at all the explored levels (P 4 0.05, after adjustment for multiple comparisons).
Brain measures
One patient was excluded from brain analyses due to motion artefacts. Four patients of 12 presented symmetrical, very faint T 2 and FLAIR hyperintensity at the level of superior cerebellar peduncles, two along the infratentorial corticospinal tract. As incidental findings, a 4-mm left anterior frontal cavernous hemangioma, a small, infracentimetric chronic lacunar lesion and a cholesterinic granuloma of the left petrous apex were observed in three patients. No evident global or selective frontal, temporal, or cerebellar Data are means AE SD. Significant differences at multiple independent samples t-test after Bonferroni correction are highlighted in bold font: Ã P 5 0.05; ÃÃ P 5 0.01; ÃÃÃ P 5 0.001. AD = axial diffusivity; FA = fractional anisotropy; MD = mean diffusivity; RD = radial diffusivity.
atrophy was observed in any of the patients on conventional MRI.
There were no statistically significant differences in cortical thickness or volume in the adrenomyeloneuropathy patient group compared to controls (P 4 0.05, after adjustment for multiple comparisons). No significant cortical DTI value alterations were also observed (P 4 0.05, after adjustment for multiple comparisons).
TBSS analysis showed a widespread, strong reduction of fractional anisotropy in several white matter tracts in adrenomyeloneuropathy patients with respect to control subjects (P 5 0.001): there was a symmetrical pattern of decrease of fractional anisotropy along the entire corticospinal tract (at the level of the brainstem, posterior limb of the internal capsules, corona radiata), both the optic radiations, the splenium of corpus callosum and both the superior cerebellar peduncles (Fig. 3) . The areas of increased radial diffusivity closely matched those of reduced fractional anisotropy, but they were more distributed to most of the associative white matter tracts (Fig. 3) , including the superior longitudinal fasciculi, external capsules, uncinate fasciculi and the genu of the corpus callosum (P 5 0.001). No axial diffusivity differences were found between adrenomyeloneuropathy patients and control subjects (P 4 0.05).
The results for the fractional anisotropy and radial diffusivity values along the main descending tracts (i.e. the corticospinal tracts) were also confirmed by the tractography-based analysis (Table 4 and Fig. 4) . The reduction of fractional anisotropy was more pronounced at the lower corticospinal tract segments (medulla and pons, followed by the midbrain and internal capsule segments, Fig. 4) . No significant differences of fractional anisotropy values between patients and controls were found at the upper corticospinal tract levels (corona radiata and subcortical white matter, P 4 0.05 after adjustment for multiple comparisons).
There was a correlation between radial diffusivity along the entire corticospinal tract and disease duration (r = 0.806, P = 0.009, considering age as covariate). No other significant correlation was found.
Discussion
In this cross-sectional study we assessed the feasibility of quantitative MRI-derived measures to characterize the structural changes of the upper spinal cord and brain of a cohort of patients with adrenomyeloneuropathy, and their relationship with the clinical status of the patients. The major findings are as follows: first, quantitative MRI of the spinal cord can reliably measure the total crosssectional area (total cord area) at cervical and upper thoracic levels of patients with adrenomyeloneuropathy. As expected, based on pathological findings and conventional MRI (Powers et al., 2000; Israel et al., 2005; Semmler et al., 2008) , total cord area was significantly reduced at each investigated level in comparison with age-matched healthy controls, and therefore it might be a reliable marker to quantify the degree of neurodegeneration. Second, in patients with adrenomyeloneuropathy, DTI-derived measures demonstrate changes in the axial and radial diffusivity of the cervical spinal cord white matter that are in agreement with the spinal cord pathology of the disease. In fact, the increase of radial diffusivity suggests the presence of myelin loss, whereas the decrease of axial diffusivity suggests the presence of axonal damage (Alexander et al., 2007) , and adrenomyeloneuropathy myelopathy is essentially characterized by the co-existence of myelin and axonal loss in the posterior and lateral columns of the spinal cord white matter (Powers et al., 2000) . Third, DTI-derived measures can reveal and quantify abnormalities undetectable by conventional MRI in numerous white matter tracts of the brain, including the corticospinal tracts, optic radiations, splenium of corpus callosum, and superior cerebellar peduncles, but not in the brain's grey matter. In particular, there is an increase of radial diffusivity without axial diffusivity changes along these tracts in subjects with a variably long history of neurological symptoms, suggesting that, at least in the brain, demyelination precedes axonal degeneration. Of note, these data are in agreement with the few neuropathological reports of the brain of patients with adrenomyeloneuropathy, showing that the white matter is characterized by microscopic demyelination foci with relative to total axonal sparing, whereas the grey matter is normal (Probst et al., 1980; Powers, 1985; Powers et al., 2000) . Finally, we found no correlation between the disability assessed by standardized clinical scales and different Data are means AE SD. Significant differences at multiple independent samples t-test after Bonferroni correction are highlighted in bold font: Ã P 5 0.05; ÃÃ P 5 0.01; ÃÃÃ P 5 0.001. AD = axial diffusivity; FA = fractional anisotropy; MD = mean diffusivity; RD = radial diffusivity. Figure 3 Brain TBSS analysis, voxelwise group differences between patients and controls. (A) In red-yellow voxels of fractional anisotropy reduction (P 5 0.001, corrected for multiple comparisons) are displayed on the images of the MNI standard brain. In the patient group a symmetrical decrease of fractional anisotropy was observed along the corticospinal tracts, optic radiations, the splenium of corpus callosum and superior cerebellar peduncles. (B) In blue-light blue voxels of radial diffusivity increase (P 5 0.001, corrected for multiple comparisons) are displayed on the images of the MNI standard brain. In the patients group, the areas of increased radial diffusivity closely matched those of reduced fractional anisotropy, but they were more distributed to most of the associative white matter tracts including the superior longitudinal fasciculi, external capsules, uncinate fasciculi and the genu of the corpus callosum.
quantitative MRI-derived measures, with the exception of a correlation between the average radial diffusivity along the corticospinal tract in the brain and disease duration.
Regarding the physiopathology of adrenomyeloneuropathy, it is still a matter of debate whether the primary lesion is multi-segmental demyelination or dying-back axonopathy (Probst et al., 1980; Powers et al., 2000) . With few exceptions (i.e. the neurons of dorsal root ganglia) (Hoftberger et al., 2007) , the mutant ABCD1 protein is expressed in glial cells, i.e. astrocytes, microglia, and oligodendrocyte subpopulations (Fouquet et al., 1997) , suggesting that myelin may be the primary site of adrenomyeloneuropathy pathology. More importantly, in a patient Data are mean AE SD. Significant differences at multiple independent samples t-test after Bonferroni correction are highlighted in bold font: Ã P 5 0.05; ÃÃ P 5 0.01; ÃÃÃ P 5 0.001. AD = axial diffusivity; FA = fractional anisotropy; MD = mean diffusivity; RD = radial diffusivity.
suffering from adrenomyeloneuropathy who died at age 24, only 2 years after the onset of his progressive spastic paraplegia, there was incomplete symmetrical demyelination at the different levels of the corticospinal tracts from the midbrain to the lumbar cord, as well as similar demyelination in other tracts, including the fasciculus gracile and superior cerebellar peduncle, whereas axons were well preserved (Budka et al., 1976) . Our findings support the thesis that the primary lesion in adrenomyeloneuropathy is multi-segmental demyelination, which might lead to a dying-back degeneration, i.e. a degeneration that is most prominent in the distal portion of the axon of the long tracts, by extending over a certain number of internodes (Probst et al., 1980) . Indeed, in the brain, the fundamental DTIderived change in our subjects was only the increase of radial diffusivity, which suggests demyelination rather than axonal damage. In contrast, in the white matter of the upper spinal cord, we found an increase of radial diffusivity and a decrease of axial diffusivity, which suggest the co-presence of myelin and axonal loss both in the lateral columns, where a more distal part of the descending corticospinal tract is located, and in the posterior columns, where the most distal parts of the ascending gracile and dorsal spino-cerebellar tracts are located.
The co-presence of demyelination and axonal degeneration at similar extent in the spinal cord may also explain why in adrenomyeloneuropathy, there is a significant reduction of the cross-sectional area, unlike other forms of spastic paraplegias, including SPG4, where the crosssectional area at cervical and thoracic segments can be normal, or only mildly reduced (Krabbe et al., 1997; Deluca et al., 2004) . The degree of spinal cord atrophy may depend on the degree of axonal loss, which may be more prominent in some types of hereditary spastic paraplegia, and thus explain why they are characterized by marked atrophy of the cervical and thoracic segments (Hedera et al., 2005) . However, it may also depend on the degree of demyelination, which can be more marked if it is primary as supposed in adrenomyeloneuropathy (Probst et al., 1980) , rather than secondary to axonal loss (Deluca et al., 2004) .
The meaning of the changes of the fractional anisotropy in the grey matter of the lower level of the spinal cord is unclear, because neuronal loss has not been reported in adrenomyeloneuropathy, with the exception of atrophy of the dorsal root ganglia (Powers et al., 2001 ) and a moderate neuronal loss in the dorsal nucleus of Clarke in one patient (Schaumburg et al., 1977) . The dorsal nucleus of Clarke, however, is present only at spinal segments C8-L3. Analogously it is unclear why no significant difference of the DTI-derived measures was found at the upper corticospinal tract levels. Different levels of ABCD1 protein expression in oligodendrocytes located in different white matter regions can explain different degrees of demyelination (Fouquet et al., 1997) , but it should be also noted that subtle changes of DTI-derived measure may not be revealed in white matter regions like corona radiata with low coherence of the white matter fibres.
To our knowledge, this is the first study that assesses spinal cord DTI-derived measures, and brain radial and axial diffusivity values in individuals with adrenomyeloneuropathy. As regards to the brain, corticospinal tractspecific fractional anisotropy and mean diffusivity, i.e. the trace (Tr) divided by 3 (mean diffusivity = Tr/3), values are coherent to those of a previous study of individuals with adrenomyeloneuropathy, despite method differences [fractional anisotropy = 0.49 AE 0.03 versus 0.52 AE 0.03; Trace ( Â10 À3 mm 2 /s) = 2.3 AE 0.11 versus 2.5 AE 0.05], thus confirming the robustness of these measures (Dubey et al., 2005) .
We found no correlation between the severity or duration of the disease and the degree of spinal cord atrophy, as reported by others in distinct subtypes of hereditary spastic paraplegias (Hedera et al., 2005; Agosta et al., 2015) . Moreover, as in an earlier study of patients with adrenomyeloneuropathy (Dubey et al., 2005) , we found no correlation between disease severity and DTI-derived measures along the corticospinal tract in the brain. We only found a correlation between disease duration and increase of radial diffusivity along the entire corticospinal tract, suggesting that demyelination along this tract increases over time, but this correlation needs to be considered with caution given the limited number of patients. Finally, at all levels of the spinal cord investigated, we have found no correlation between the duration or severity of the disease and the extent of DTI-derived measure changes, including the decrease of axial diffusivity, which may be related to axonal damage. Differences among groups with distinct levels of disability cannot be demonstrated due to the lack of sufficient sample size (Dubey et al., 2005) , but it should be noted that the patient with the best clinical scores showed the most similar to the normal quantitative MRIderived measures.
This lack of correlations may suggest that the disease severity, at least in the early stage, depends more on axonal dysfunction than on axonal loss and spinal cord atrophy (Deluca et al., 2004) . In fact, axonal dysfunction might also depend on the degree of demyelination, and initial axonal loss can be partially counteracted by neuroaxonal redundancy or adaptative neuroplasticity (Jenkins et al., 2010) . For instance, the Ambulation Index of one of the patients was 6 when he underwent quantitative MRI, i.e. he required bilateral support and 420 s to walk 25 feet, but improved to 4 a few weeks after intensive physiotherapy, i.e. he required unilateral support to walk, and walked 25 feet in 420 s. It is unlikely that the improvement of his motor performance is related to microstructural changes that can be assessed by DTI-derived measures, strongly suggesting a discrepancy between functional and structural changes in the disease evolution. This discrepancy highlights the need to assess both aspects to better understand the physiopathology of the disease and to monitor the effect of a given therapy on the disease course.
In conclusion, we provide definite evidence that quantitative MRI techniques are feasible in clinical practice to measure the structural changes of the brain and cervical spinal cord of subjects with adrenomyeloneuropathy. Quantitative MRI techniques may also be more reliable to demonstrate structural changes reflecting disease progression than previously used clinical disability scores. Our findings strongly suggest use of these techniques in a multi-centric cohort of patients with adrenomyeloneuropathy and possibly in other hereditary spastic paraplegias, to define their validity to investigate in vivo the underlying structural changes at the brain and spinal cord level, as well as to assess the disease progression, and the effects of new disease-modifying therapies.
